Murine Creld1 controls cardiac development through activation of calcineurin/NFATc1 signaling

Developmental Cell

Volumn 28, Issue 6, 2014, Pages 711-726

  Mass, Elvira ^a   Wachten, Dagmar ^b   Aschenbrenner, Anna C ^a   Voelzmann, André ^a   Hoch, Michael ^a  

^a UNIVERSITY OF BONN   (Germany)

^b CENTER OF ADVANCED EUROPEAN STUDIES AND RESEARCH CAESAR   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CRELD1 PROTEIN; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC1; UNCLASSIFIED DRUG; VASCULOTROPIN; CALCIUM; CELL ADHESION MOLECULE; CRELD1 PROTEIN, MOUSE; MESSENGER RNA; NFATC1 PROTEIN, MOUSE; SCLEROPROTEIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A; CYSTEINE RICH WITH EGF LIKE DOMAIN 1 PROTEIN; PEPTIDES AND PROTEINS;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; ENDOCARDIUM; ENDOPLASMIC RETICULUM; HEART DEVELOPMENT; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; 3T3 CELL LINE; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; CYTOPLASM; EMBRYOLOGY; GENETICS; HEART; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; METABOLISM; MUTATION; PHOSPHORYLATION; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL EXPERIMENT; EMBRYO;

ANIMALS; BLOTTING, WESTERN; CALCINEURIN; CALCIUM; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; CYTOPLASM; ENDOCARDIUM; ENDOPLASMIC RETICULUM; EXTRACELLULAR MATRIX PROTEINS; HEART; HUMANS; IMMUNOPRECIPITATION; MICE; MICE, KNOCKOUT; MUTATION; NFATC TRANSCRIPTION FACTORS; NIH 3T3 CELLS; PHOSPHORYLATION; PROTEIN TRANSPORT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MURINAE; MUS;

EID: 84897077710     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2014.02.012     Document Type: Article

References (54)

1. Ackerman C., Locke A.E., Feingold E., Reshey B., Espana K., Thusberg J., Mooney S., Bean L.J., Dooley K.J., Cua C.L., et al. An excess of deleterious variants in VEGF-A pathway genes in Down-syndrome-associated atrioventricular septal defects. Am. J. Hum. Genet. 2012, 91:646-659.
2. Arron J.R., Winslow M.M., Polleri A., Chang C.P., Wu H., Gao X., Neilson J.R., Chen L., Heit J.J., Kim S.K., et al. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 2006, 441:595-600.
3. Bandyopadhyay A., Shin D.W., Ahn J.O., Kim D.H. Calcineurin regulates ryanodine receptor/Ca(2+)-release channels in rat heart. Biochem. J. 2000, 352:61-70.
4. Cameron A.M., Steiner J.P., Roskams A.J., Ali S.M., Ronnett G.V., Snyder S.H. Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux. Cell 1995, 83:463-472.
5. Chan B., Greenan G., McKeon F., Ellenberger T. Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity invitro and invivo. Proc. Natl. Acad. Sci. USA 2005, 102:13075-13080.
6. Chang C.P., Neilson J.R., Bayle J.H., Gestwicki J.E., Kuo A., Stankunas K., Graef I.A., Crabtree G.R. A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis. Cell 2004, 118:649-663.
7. Chen F., Kook H., Milewski R., Gitler A.D., Lu M.M., Li J., Nazarian R., Schnepp R., Jen K., Biben C., et al. Hop is an unusual homeobox gene that modulates cardiac development. Cell 2002, 110:713-723.
8. Clipstone N.A., Crabtree G.R. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 1992, 357:695-697.
9. Combs M.D., Yutzey K.E. Heart valve development: regulatory networks in development and disease. Circ. Res. 2009, 105:408-421.
10. Combs M.D., Yutzey K.E. VEGF and RANKL regulation of NFATc1 in heart valve development. Circ. Res. 2009, 105:565-574.
11. Crabtree G.R., Olson E.N. NFAT signaling: choreographing the social lives of cells. Cell 2002, 109(Suppl):S67-S79.
12. de la Pompa J.L., Timmerman L.A., Takimoto H., Yoshida H., Elia A.J., Samper E., Potter J., Wakeham A., Marengere L., Langille B.L., et al. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 1998, 392:182-186.
13. Dor Y., Camenisch T.D., Itin A., Fishman G.I., McDonald J.A., Carmeliet P., Keshet E. A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. Development 2001, 128:1531-1538.
14. Eisenberg L.M., Markwald R.R. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ. Res. 1995, 77:1-6.
15. Feng Q., Di R., Tao F., Chang Z., Lu S., Fan W., Shan C., Li X., Yang Z. PDK1 regulates vascular remodeling and promotes epithelial-mesenchymal transition in cardiac development. Mol. Cell. Biol. 2010, 30:3711-3721.
16. Flanagan W.M., Corthésy B., Bram R.J., Crabtree G.R. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 1991, 352:803-807.
17. Fuentes J.J., Pritchard M.A., Planas A.M., Bosch A., Ferrer I., Estivill X. A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart. Hum. Mol. Genet. 1995, 4:1935-1944.
18. Fuentes J.J., Genescà L., Kingsbury T.J., Cunningham K.W., Pérez-Riba M., Estivill X., de la Luna S. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum. Mol. Genet. 2000, 9:1681-1690.
19. Gaborit N., Sakuma R., Wylie J.N., Kim K.H., Zhang S.S., Hui C.C., Bruneau B.G. Cooperative and antagonistic roles for Irx3 and Irx5 in cardiac morphogenesis and postnatal physiology. Development 2012, 139:4007-4019.
20. Giffin M.J., Stroud J.C., Bates D.L., von Koenig K.D., Hardin J., Chen L. Structure of NFAT1 bound as a dimer to the HIV-1 LTR kappa B element. Nat. Struct. Biol. 2003, 10:800-806.
21. Graef I.A., Chen F., Chen L., Kuo A., Crabtree G.R. Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell 2001, 105:863-875.
22. Grego-Bessa J., Luna-Zurita L., del Monte G., Bolós V., Melgar P., Arandilla A., Garratt A.N., Zang H., Mukouyama Y.S., Chen H., et al. Notch signaling is essential for ventricular chamber development. Dev. Cell 2007, 12:415-429.
23. Hansen H.G., Schmidt J.D., Søltoft C.L., Ramming T., Geertz-Hansen H.M., Christensen B., Sørensen E.S., Juncker A.S., Appenzeller-Herzog C., Ellgaard L. Hyperactivity of the Ero1α oxidase elicits endoplasmic reticulum stress but no broad antioxidant response. J.Biol. Chem. 2012, 287:39513-39523.
24. Hinton R.B., Lincoln J., Deutsch G.H., Osinska H., Manning P.B., Benson D.W., Yutzey K.E. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ. Res. 2006, 98:1431-1438.
25. Jain J., McCaffrey P.G., Miner Z., Kerppola T.K., Lambert J.N., Verdine G.L., Curran T., Rao A. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 1993, 365:352-355.
26. Jin L., Sliz P., Chen L., Macián F., Rao A., Hogan P.G., Harrison S.C. An asymmetric NFAT1 dimer on a pseudo-palindromic kappa B-like DNA site. Nat. Struct. Biol. 2003, 10:807-811.
27. Johnson E.N., Lee Y.M., Sander T.L., Rabkin E., Schoen F.J., Kaushal S., Bischoff J. NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells. J.Biol. Chem. 2003, 278:1686-1692.
28. King T., Bland Y., Webb S., Barton S., Brown N.A. Expression of Peg1 (Mest) in the developing mouse heart: involvement in trabeculation. Dev. Dyn. 2002, 225:212-215.
29. Klee C.B., Crouch T.H., Krinks M.H. Calcineurin: a calcium- and calmodulin-binding protein of the nervous system. Proc. Natl. Acad. Sci. USA 1979, 76:6270-6273.
30. Lange A.W., Molkentin J.D., Yutzey K.E. DSCR1 gene expression is dependent on NFATc1 during cardiac valve formation and colocalizes with anomalous organ development in trisomy 16 mice. Dev. Biol. 2004, 266:346-360.
31. Li H., Rao A., Hogan P.G. Interaction of calcineurin with substrates and targeting proteins. Trends Cell Biol. 2011, 21:91-103.
32. Liu J., Farmer J.D., Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991, 66:807-815.
33. Lorenz H., Hailey D.W., Lippincott-Schwartz J. Fluorescence protease protection of GFP chimeras to reveal protein topology and subcellular localization. Nat. Methods 2006, 3:205-210.
34. Maslen C.L., Babcock D., Robinson S.W., Bean L.J., Dooley K.J., Willour V.L., Sherman S.L. CRELD1 mutations contribute to the occurrence of cardiac atrioventricular septal defects in Down syndrome. Am. J. Med. Genet. A. 2006, 140:2501-2505.
35. McCaffrey P.G., Luo C., Kerppola T.K., Jain J., Badalian T.M., Ho A.M., Burgeon E., Lane W.S., Lambert J.N., Curran T., et al. Isolation of the cyclosporin-sensitive Tcell transcription factor NFATp. Science 1993, 262:750-754.
36. Molkentin J.D. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc. Res. 2004, 63:467-475.
37. Oh-hashi K., Koga H., Ikeda S., Shimada K., Hirata Y., Kiuchi K. CRELD2 is a novel endoplasmic reticulum stress-inducible gene. Biochem. Biophys. Res. Commun. 2009, 387:504-510.
38. Oh-hashi K., Kunieda R., Hirata Y., Kiuchi K. Biosynthesis and secretion of mouse cysteine-rich with EGF-like domains 2. FEBS Lett. 2011, 585:2481-2487.
39. Ranger A.M., Grusby M.J., Hodge M.R., Gravallese E.M., de la Brousse F.C., Hoey T., Mickanin C., Baldwin H.S., Glimcher L.H. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 1998, 392:186-190.
40. Rinne A., Blatter L.A. Activation of NFATc1 is directly mediated by IP3 in adult cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 2010, 299:H1701-H1707.
41. Robinson S.W., Morris C.D., Goldmuntz E., Reller M.D., Jones M.A., Steiner R.D., Maslen C.L. Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects. Am. J. Hum. Genet. 2003, 72:1047-1052.
42. Rothermel B., Vega R.B., Yang J., Wu H., Bassel-Duby R., Williams R.S. A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J.Biol. Chem. 2000, 275:8719-8725.
43. Rupp P.A., Fouad G.T., Egelston C.A., Reifsteck C.A., Olson S.B., Knosp W.M., Glanville R.W., Thornburg K.L., Robinson S.W., Maslen C.L. Identification, genomic organization and mRNA expression of CRELD1, the founding member of a unique family of matricellular proteins. Gene 2002, 293:47-57.
44. Sanna B., Brandt E.B., Kaiser R.A., Pfluger P., Witt S.A., Kimball T.R., van Rooij E., De Windt L.J., Rothenberg M.E., Tschop M.H., et al. Modulatory calcineurin-interacting proteins 1 and 2 function as calcineurin facilitators invivo. Proc. Natl. Acad. Sci. USA 2006, 103:7327-7332.
45. Savolainen S.M., Foley J.F., Elmore S.A. Histology atlas of the developing mouse heart with emphasis on E11.5 to E18.5. Toxicol. Pathol. 2009, 37:395-414.
46. Schreiber S.L. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 1991, 251:283-287.
47. Vega R.B., Rothermel B.A., Weinheimer C.J., Kovacs A., Naseem R.H., Bassel-Duby R., Williams R.S., Olson E.N. Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 2003, 100:669-674.
48. Walter P., Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 2011, 334:1081-1086.
49. Wu H., Kao S.C., Barrientos T., Baldwin S.H., Olson E.N., Crabtree G.R., Zhou B., Chang C.P. Down syndrome critical region-1 is a transcriptional target of nuclear factor of activated Tcells-c1 within the endocardium during heart development. J.Biol. Chem. 2007, 282:30673-30679.
50. Wu B., Wang Y., Lui W., Langworthy M., Tompkins K.L., Hatzopoulos A.K., Baldwin H.S., Zhou B. Nfatc1 coordinates valve endocardial cell lineage development required for heart valve formation. Circ. Res. 2011, 109:183-192.
51. Xiong Y., Zhou B., Chang C.P. Analysis of the endocardial-to-mesenchymal transformation of heart valve development by collagen gel culture assay. Methods Mol. Biol. 2012, 843:101-109.
52. Xu J. Preparation, culture, and immortalization of mouse embryonic fibroblasts. Curr. Protoc. Mol. Biol. 2005, Chapter 28. Unit 28 21.
53. Yang J., Rothermel B., Vega R.B., Frey N., McKinsey T.A., Olson E.N., Bassel-Duby R., Williams R.S. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ. Res. 2000, 87:E61-E68.
54. Zhou B., Wu B., Tompkins K.L., Boyer K.L., Grindley J.C., Baldwin H.S. Characterization of Nfatc1 regulation identifies an enhancer required for gene expression that is specific to pro-valve endocardial cells in the developing heart. Development 2005, 132:1137-1146.